PRDM9 and Peritoneal Fibrosis: Previous studies have found that epigenetic drugs targeting histone acetylation/deacetylation (HAT or HDAC inhibitors), histone/DNA methylation, or histone methyltransferase activities, modulated experimentally induced peritoneal fibrosis [6,7,8,62].